Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats

Neurochemical Research

Volumn 33, Issue 6, 2008, Pages 985-995

  Banerjee, Rebecca ^a   Saravanan, Karuppagounder S ^a,b   Thomas, Bobby ^a,c   Sindhu, Kizhake M ^a   Mohanakumar, Kochupurackal P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b BURKE REHABILITATION HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Fenton like reaction; Hemiparkinsonian animal model; Hydroxyl radicals; Mitochondria; Neuroprotection; Nitric oxide donors; Parkinson's disease; Striatum; Substantia nigra

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; FERROUS CITRATE; FERROUS ION; GLYCERYL TRINITRATE; HYDROXYL RADICAL; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; SCAVENGER; UNCLASSIFIED DRUG;

AIR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DRUG ADMINISTRATION ROUTE; FENTON REACTION; INTRANIGRAL DRUG ADMINISTRATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REACTION ANALYSIS; SPRAGUE DAWLEY RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CORPUS STRIATUM; DOPAMINE; HUMANS; HYDROXYL RADICAL; MALE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITRIC OXIDE DONORS; RATS; RATS, SPRAGUE-DAWLEY; SALICYLATES; SUBSTANTIA NIGRA;

ANIMALIA; PARKINSONIA; RATTUS;

EID: 42149116437     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9473-z     Document Type: Article

References (65)

1. +), identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci Lett 48:87-92
2. Gainetdinov RR, Fumagili F, Jones SR et al (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity, evidence from mice lacking the transporter. J Neurochem 69:1322-1325
3. Castagnoli K, Palmer S, Anderson A et al (1997) The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chem Res Toxicol 10:364-368
4. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36:2503-2568
5. + induced oxygen radical formation with mitochondrial enzymes. Free Radic Biol Med 15:181-186
6. Chiueh CC, Wu R-M, Mohanakumar KP et al (1994) In vivo formation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann NY Acad Sci 738:25-36
7. Thomas B, Muralikrishnan D, Mohanakumar KP (2000) In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Brain Res 852:221-224
8. +. J Neural Transm 74:75-86
9. Sairam K, Saravanan KS, Banerjee R et al (2003) Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib protects against 1-methyl-4-phenylpyridinium-induced dopaminergic neurotoxicity in rats. Brain Res 966:245-252
10. + or rotenone display differential sensitivity to amphetamine and apomorphine. Pharmacol Biochem Behav 84:321-329
11. + causes damages in the cell nuclei in the striatum following intrastriatal infusion in Sprague-Dawley rats. J Chem Neuroanat 32:90-100
12. + in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences. Neurochem Res 32:1238-1247
13. Dawson VL, Dawson TM (1996) Nitric oxide neurotoxicity. J Chem Neuroanat 10:179-190
14. Mohanakumar KP, Steinbusch HWM (1998) Hydroxyl radicals and nitric oxide in neurotoxicity and neuroprotection. J Chem Neuroanat 14:125-127
15. Jackson-Lewis V, Smeyne RJ (2005) MPTP and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric oxide in neurotoxicity. Neurotox Res 7:193-202
16. Marchetti B, Serra PA, Tirolo C et al (2005) Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism, pivotal role for glia-neuron interactions. Brain Res Rev 48:302-321
17. Mohanakumar KP, Thomas B, Sharma SM et al (2002) Nitric oxide: an antioxidant and neuroprotector. Ann NY Acad Sci 962:389-401
18. Heales SJ, Lam AA, Duncan AJ, Land JM (2004) Neurodegeneration or neuroprotection, the pivotal role of astrocytes. Neurochem Res 29:513-519
19. Hogg N, Kalyanaraman B, Joseph J et al (1993) Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 334:170-174
20. Rauhala P, Mohanakumar KP, Sziraki I et al (1996) S-Nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23:58-60
21. Mohanakumar KP, Hanbauer I, Chiueh CC (1998) Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity. J Chem Neuroanat 14:195-205
22. Tsai MJ, Lee EH (1998) Nitric oxide donors protect cultured rat astrocytes from 1-methyl-4-phenylpyridinium-induced toxicity. Free Radic Biol Med 24:705-713
23. Genc S, Kuralay F, Genc K et al (2001) Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treated C57/BL mice via increasing nitric oxide production. Neurosci Lett 298:139-141
24. Wink DA, Hanbauer I, Krishna MC et al (1993) Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 90:9813-9817
25. Suschek CV, Briviba K, Bruch-Gerharz D et al (2001) Even after UVA exposure will nitric oxide protect cells from reactive oxygen intermediate-mediated apoptosis and necrosis. Cell Death Differ 8:515-527
26. Wenk GL, McGann-Gramling K, Hauss-Wegrzyniak B (2004) Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. J Neurochem 89:484-493
27. Harrison DG, Bates JN (1993) The nitrovasodilators, new ideas about old drugs. Circulation 87:1461-1467
28. Ignarro LJ, Lippton H, Edwards JC et al (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide, evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739-749
29. Hogg N, Darley-Usmar VM, Wilson MT et al (1992) Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281:419-424
30. Thomas B, Mohanakumar KP (2004) Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. J Pineal Res 36:25-32
31. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, New York
32. Mohanakumar KP, de Bartolomeis A, Wu R-M et al (1994) Ferrous citrate complex and nigral degeneration, Evidence for free radical formation and lipid peroxidation. Ann NY Acad Sci 738:392-399
33. Whittaker VP (1971) Subcellular localization of neurotransmitters. Advances in Cytopharmacology. Raven Press, New York, pp 319-330
34. Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275
35. Halliwell B, Kaur H, Ingelman-Sundberg M (1991) Hydroxylation of salicylate as an assay for hydroxyl radicals, a cautionary note. Free Radic Biol Med 10:439-441
36. Saravanan KS, Sindhu KM, Mohanakumar KP (2005) Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease. Brain Res 1049:147-155
37. Maharaj DS, Saravanan KS, Maharaj H et al (2004) Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Neurochem Intl 44:355-360
38. Knaryan VH, Samantaray S, Galoyan AA et al (2005) A synthetic human proline-rich-polypeptide enhances hydroxyl radical generation and fails to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced toxicity in mice. Neurosci Lett 375:187-191
39. Knaryan VH, Samantaray S, Varghese M et al (2006) Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced dopaminergic neurotoxicity in mice. Neuropeptides 40:291-298
40. Mladenka P, Simunek T, Hubl M et al (2006) The role of reactive oxygen and nitrogen species in cellular iron metabolism. Free Rad Res 40:263-272
41. Lim MH, Lippard SJ (2007) Metal-based turn-on fluorescent probes for sensing nitric oxide. Acc Chem Res 40:41-51
42. Moncada S, Bolanos JP (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97:1676-1689
43. Kanner J, Harel S, Granit R (1991) Nitric oxide as an antioxidant. Arch Biochem Biophys 289:130-136
44. Rubbo H, Radi R, Trujillo M et al (1994) Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269:26066-26075
45. Rauhala P, Khaldi A, Mohanakumar KP et al (1998) Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside. Free Radic Biol Med 24:1065-1073
46. Yanamoto K, Hosoi R, Uesaka Y et al (2003) Intrastriatal microinjection of sodium nitroprusside induces cell death and reduces binding of dopaminergic receptors. Synapse 50:137-143
47. Singh RJ, Hogg N, Joseph J et al (1999) The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors. Arch Biochem Biophys 361:331-339
48. Maharaj DS, Maharaj H, Daya S et al (2006) Melatonin and 6-hydroxymelatonin protect against iron-induced neurotoxicity. J Neurochem 96:78-81
49. Lipton SA, Choi YB, Pan ZH et al (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632
50. Wen Y, Perez EJ, Green PS et al (2004) nNOS is involved in estrogen mediated neuroprotection in neuroblastoma cells. Neuroreport 28:1515-1518
51. Schulz JB, Matthews RT, Muquit MMK et al (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64:936-939
52. Hantraye P, Brouillet E, Ferrante R et al (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Med 2:1017-1021
53. Przedborski S, Jackson-Lewis V, Yokoyama R et al (1996) Role of nitric oxide in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93:4565-4571
54. Klivenyi P, Andreassen OA, Ferrante R et al (2000) Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport 11:1265-1268
55. Mackenzie GM, Jackson MJ, Jenner P (1997) Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset. Synapse 26:301-316
56. +-evoked hydroxyl radical formation but not dopamine efflux in rat striatum. J Neural Transm 106:477-486
57. Lipton SA, Choi YB, Sucher NJ et al (1998) Neuroprotective versus neurodestructive effects of NO-related species. Biofactors 8:33-40
58. Itzhak Y, Martin JL, Ali SF (1999) Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice. Synapse 34:305-312
59. Kurosaki R, Muramatsu Y, Michimata M et al (2002) Role of nitric oxide synthase against MPTP neurotoxicity in mice. Neurol Res 24:655-662
60. Di Monte DA, Royland JE, Anderson A et al (1997) Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity. J Neurochem 69:1771-1773
61. Royland JE, Delfani K, Langston JW et al (1999) 7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse striatum. Brain Res 839:41-48
62. Mohanakumar KP, Muralikrishnan D, Thomas B (2000) Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Brain Res 864:281-290
63. Mohanakumar KP, Muralikrishnan D (2000) Neurochemical mechanisms underlying neuroprotective actions of bromocriptine, salicylate, d- and l-deprenyl in neurodegeneration caused by MPTP. In: Collins MA, Storch A (eds) Neurotoxic factors in Parkinson's disease and related disorders. Kluwer Academic/Plenum Press, New York, pp 289-294
64. Sziraki I, Mohanakumar KP, Rauhala P et al (1998) Manganese, a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism. Neuroscience 85:1101-1111
65. Lei S, Pan ZH, Aggarwal SK Chen HSV et al (1992) Effects of nitric oxide production on the redox modulatory site on the NMDA receptor-channel complex. Neuron 8:1087-1099